SENNOSIDES- sennosides tablet, film coated 
Major Pharmaceuticals

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

1122W-Major

Drug Facts

Active ingredient (in each tablet)
Sennosides 8.6 mg

Purpose
Laxative

Uses

 relieves occasional constipation (irregularity)
 generally produces a bowel movement in 6-12 hours

 laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

 stomach pain

 nausea

 vomiting

 noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

 take preferably at bedtime or as directed by a doctor

agestarting dosagemaximum dosage
adults and children 12
years of age and over
2 tablets once
a day
4 tablets twice
a day
children 6 to under
12 years
1 tablet once
a day
2 tablets twice
a day
children 2 to under
6 years
1/2 tablet once
a day
1 tablet twice
a day
children under
2 years
ask a doctorask a doctor

Other information

each tablet contains: calcium 20 mg.
 store in a dry place at 15° – 30°C (59° – 86°F).

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc.

Questions or comments?

1-800-616-2471

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

Distributed by:
MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268


*This product is not manufactured or distributed by Avrio Health L.P., owner of the registered trademark Senokot®.

Major

NDC 0904-7252-80

Compare to the active ingredient in Senokot® Tablets*

Senna Tablets

Sennosides

8.6 mg

Natural Vegetable Laxative Ingredient

1000 Tablets

Major Label

SENNOSIDES 
sennosides tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-7252
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
TALC (UNII: 7SEV7J4R1U)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
LIGHT MINERAL OIL (UNII: N6K5787QVP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize9mm
FlavorImprint Code W2
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0904-7252-60100 in 1 BOTTLE; Type 0: Not a Combination Product05/17/2022
2NDC:0904-7252-801000 in 1 BOTTLE; Type 0: Not a Combination Product05/17/2022
3NDC:0904-7252-6110 in 1 BOX, UNIT-DOSE05/17/2022
310 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33405/17/2022
Labeler - Major Pharmaceuticals (191427277)

Revised: 5/2022
Document Id: df3b431b-a1ae-91dd-e053-2995a90aa02f
Set id: df3b431b-a1ad-91dd-e053-2995a90aa02f
Version: 1
Effective Time: 20220517
 
Major Pharmaceuticals